August 18, 2010 - Bayer AG Agrees To Pay $60 Million To Settle Some Trasylol Lawsuits.

Bloomberg News (8/18, Feeley) reports, "Bayer AG agreed to pay at least $60 million to settle about 150 lawsuits over Trasylol [aprotinin injection], a drug used to control bleeding during heart surgeries, people familiar with the accords said." Specifically, "the settlements, which Bayer announced in court earlier this month, provide an average payout of about $400,000 per patient…” Trasylol was pulled off the market in 2007, around 14 years after it was approved in the US, and two years after research was published indicating a higher risk of death than competing drugs.